文献速递主动脉疾病外周动脉疾病

血管腔内动脉瘤修复术中困难入路的管理

Management of Difficult Access during Endovascular Aneurysm Repair.
PubMed 文献 · Ann Vasc Surg · 2017-05-04

该回顾性单中心研究分析了2009至2013年400例EVAR患者,其中48%存在双侧髂动脉直径小于7 mm的困难入路。困难入路患者中18.3%使用了辅助操作,辅助操作组输送主体的髂动脉平均直径4.6 mm,低于未辅助组的5.4 mm(P=0.008)。结论认为双侧髂动脉细小患者仍可成功行EVAR,辅助操作可提高技术成功率,髂动脉直径小于5 mm时应考虑辅助操作。

要点

  • 双侧髂动脉直径小于7 mm定义为困难入路,占EVAR患者的48%。
  • 困难入路患者中18.3%需辅助操作,辅助组髂动脉平均直径4.6 mm显著小于未辅助组5.4 mm。
  • 髂动脉直径小于5 mm时建议考虑辅助操作以提高EVAR技术成功率。

核心结论

  • 双侧髂动脉细小患者可成功行EVAR,辅助操作可能提高技术成功率,髂动脉直径小于5 mm时应考虑辅助操作。

研究设计与样本

  • 回顾性单中心研究,纳入2009至2013年三级学术医学中心所有行EVAR的患者共400例,中位随访38个月,排除开窗和烟囱修复。

主要发现

  • 400例EVAR中191例(48%)存在困难入路,其中35例(18.3%)在主件置入前接受了42次辅助操作。
  • 辅助操作组输送主体的髂动脉平均直径4.6 mm,未辅助的困难入路组为5.4 mm(P=0.008)。
  • 2例因无法输送装置而中止手术,7例(3.6%)髂动脉破裂,3例(1.6%)肢体缺血,5例(2.6%)30天内再手术。
  • 随访中12例(6.3%)需EVAR修正,7例(3.6%)肢体血栓形成且均发生于初始EVAR未行辅助操作的患者。
  • 困难入路患者的肢体血栓形成率和修正率与非困难入路患者无显著差异;择期修复围术期死亡率困难入路组1.6%,非困难入路组0%(P=0.12)。

关键数值与推荐

  • 困难入路定义为双侧髂动脉直径小于7 mm。
  • 辅助操作包括15例扩张器、11例球囊血管成形术、9例主髂动脉单侧装置、3例SoloPath鞘、1例腹膜后切开和3例髂动脉支架。
  • 另有29例在EVAR装置置入后使用髂动脉支架纠正肢体狭窄或扭结。
  • 主件装置中位尺寸为28 mm。
  • EVAR结束时2例(1%)存在I型内漏。

临床怎么用

  • 对于双侧髂动脉直径小于7 mm的困难入路患者,EVAR仍可成功实施,但应预先规划辅助操作。
  • 髂动脉直径小于5 mm时,应积极考虑辅助操作以提高装置输送成功率。
  • 下一代低剖面装置可能减少辅助操作需求并简化困难入路患者的EVAR。

局限性

  • 回顾性单中心研究,样本来自单一三级学术医学中心。
  • 困难入路定义仅基于髂动脉直径小于7 mm,未纳入其他解剖因素。
  • 排除开窗和烟囱修复,结论不适用于这些复杂修复方式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To describe a large single-institutional experience in managing challenging access situations during endovascular aneurysm repair (EVAR). METHODS: Data from all patients undergoing EVAR at a tertiary academic medical center between 2009 and 2013 were collected retrospectively, including demographics, size of iliac arteries, type of device used, approach to managing difficult access (DA), and outcomes. The median follow-up was 38 months. DA was defined as iliac arteries with a diameter of less than 7 mm bilaterally. Fenestrated and snorkel repairs were excluded. RESULTS: Of 400 EVARs performed during the study period, 191 (48%) were done in patients with DA. Of the DA patients, 35 (18.3%) underwent 42 adjuncts before the introduction of the main body device: including 15 dilators, 11 balloon angioplasties, 9 aortouniiliac devices, 3 SoloPath sheaths, 1 retroperitoneal cutdown, and 3 iliac stents. In another 29 patients, iliac stents were used to correct stenoses or kinks in the limbs after EVAR devices were deployed. The average diameter of the iliac artery used to deliver main body component was 4.6 mm in the group of patients requiring adjuncts and 5.4 mm in the remainder of the patients with small iliac arteries (P = 0.008). The median size of the main body device was 28 mm. Two cases were aborted due to inability to deliver the device. Other complications included 7 (3.6%) iliac ruptures, 3 (1.6%) instances of limb ischemia, and 5 (2.6%) patients needed early reoperation (within 30 days). Two patients (1%) had type I endoleaks at the conclusion of EVAR. During follow-up, 12 (6.3%) patients required EVAR revisions. Seven patients (3.6%) had limb thrombosis which occurred only in patients who did not have adjective procedures during the initial EVAR. Limb thrombosis and rate of revisions in patients with DA were not significantly different from the rates observed in non-DA patients. Perioperative mortality after elective repairs was 1.6% in DA patients and 0% in non-DA patients (P = 0.12). CONCLUSIONS: EVAR can be successfully performed in patients with bilateral small iliac arteries. Adjunctive procedures might increase the technical success rate of EVAR in these patients and should definitely be considered in patients with iliac arteries less than 5 mm in diameter. Next generation and "low-profile" devices might minimize the need for adjunctive procedures and facilitate EVAR in these patients.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Etkin Y, Baig A, Foley PJ, et al. Management of Difficult Access during Endovascular Aneurysm Repair. Ann Vasc Surg. 2017. PMID: 28479422. doi:10.1016/j.avsg.2017.03.190

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。